Shanshan Liang

The Key Laboratory of biomarker high throughput screening and target translation of breast and gastrointestinal tumor, Affiliated Zhongshan Hospital of Dalian University

Affiliated withAffiliated Zhongshan Hospital of Dalian University

Research Area

Cancer Research

Biography

Shanshan Liang has not added Biography.
If you are Shanshan Liang and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 1	2025

Other Publications

Article	Year
Dominant-negative p53 mutant R248Q increases the motile and invasive activities of oral squamous cell carcinoma cells. Biomedical research (Tokyo, Japan)\| PubMed ID: 30787262	2019
IGF-1R Inhibition Suppresses Cell Proliferation and Increases Radiosensitivity in Nasopharyngeal Carcinoma Cells. Mediators of inflammation\| PubMed ID: 31467485	2019
Prognostic significance of PD-L1 expression on cell-surface vimentin-positive circulating tumor cells in gastric cancer patients. Molecular oncology\| PubMed ID: 31981446	2020
Cepharanthine attenuates cerebral ischemia/reperfusion injury by reducing NLRP3 inflammasome-induced inflammation and oxidative stress via inhibiting 12/15-LOX signaling. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie\| PubMed ID: 32559840	2020
NONO Is a Negative Regulator of Promoter. Cancer genomics & proteomics\| PubMed ID: 32576581	2020
Metformin reverses the drug resistance of cisplatin in irradiated CNE-1 human nasopharyngeal carcinoma cells through PECAM-1 mediated MRPs down-regulation. International journal of medical sciences\| PubMed ID: 33029084	2020
Label-free surface-enhanced Raman spectroscopy for diagnosis and analysis of serum samples with different types lung cancer. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy\| PubMed ID: 34116414	2021
Effect of repetitive transcranial magnetic stimulation on patients with severe depression: a study protocol for systematic review and meta-analysis of randomised clinical trials. BMJ open\| PubMed ID: 34907048	2021
Activation of SSAT1/ALOX15 Axis Aggravates Cerebral Ischemia/Reperfusion Injury via Triggering Neuronal Ferroptosis. Neuroscience\| PubMed ID: 35090880	2022
Circulating tumor cells and neutrophil-lymphocyte ratio are predictive markers for metastatic colorectal cancer patients. Translational cancer research\| PubMed ID: 35116260	2021
Radiation induces epithelial to mesenchymal transition via upregulation of PD-L1 in nasopharyngeal carcinoma cell. Translational cancer research\| PubMed ID: 35116267	2021
The prognostic role of a combined fibrinogen and inflammation-based index in patients with metastatic breast cancer. Translational cancer research\| PubMed ID: 35117312	2020
Potential protective benefits of Schisandrin B against severe acute hepatitis in children during the COVID-19 pandemic based on a network pharmacology analysis. Frontiers in pharmacology\| PubMed ID: 36034788	2022
Extracellular matrix stiffness mediates radiosensitivity in a 3D nasopharyngeal carcinoma model. Cancer cell international\| PubMed ID: 36403050	2022
Patient-derived organoid elucidates the identical clonal origin of bilateral breast cancer with diverse molecular subtypes. Frontiers in oncology\| PubMed ID: 38800414	2024
Reconstructing tumor clonal heterogeneity and evolutionary relationships based on tumor DNA sequencing data. Briefings in bioinformatics\| PubMed ID: 39413797	2024
High-throughput solutions in tumor organoids: from culture to drug screening. Stem cells (Dayton, Ohio)\| PubMed ID: 39460616	2025
Malignant pleural effusion facilitates the establishment and maintenance of tumor organoid biobank with multiple patient-derived lung tumor cell sources. Experimental hematology & oncology\| PubMed ID: 39548571	2024
Lung tumor organoids migrate as cell clusters containing cancer stem cells under hypoxic condition. Biology of the cell\| PubMed ID: 39924834	2025
Molecular interaction study of flavonols with human serum albumin by theoretical simulations. Journal of biomolecular structure & dynamics\| PubMed ID: 39985807	2025
A comprehensive review of Schisandrin B's preclinical antitumor activity and mechanistic insights from network pharmacology. Frontiers in pharmacology\| PubMed ID: 39995410	2025
Schisandrin B targets CDK4/6 to suppress proliferation and enhance radiosensitivity in nasopharyngeal carcinoma by inducing cell cycle arrest. Scientific reports\| PubMed ID: 40069371	2025